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Soft tissue sarcomas are the sixth most common malignancy in childhood and rhabdomyosarcotmas constitute about 50% of soft tissue sarcot
mas. This tumor accounts for 10% to 15% of solid mat
lignant tumors and 6% of all malignancies in children 
under 15 years of age. In the United States, the malet
totfemale ratio is 1.5:1, and the tumor is twice as comt
mon in whites as in AfricantAmericans. Approximately 
250 new cases are diagnosed every year.1
Rhabdomyosarcoma is a malignant tumor of strit
ated muscle but, because of its mesenchymal origin, 
can originate in tissue that does not normally contain 
striated muscle (for example, the ureter). There is a bit
modal distribution of rhabdomyosarcoma with peaks 
between 2 and 4 years of age and 12 and 16 years of 
age. Nearly 80% of rhabdomyosarcoma is diagnosed by 
the age of 14 years. The most common primary sites 
for rhabdomyosarcomas include the head and neck, the 
genitourinary tract, and extremities. However, primary 
sites with a favorable prognosis include the orbit and 
nonparameningeal, head and neck, paratestis, the vat
gina, and the biliary tract.2,3
CASE
A 3tyeartold female had a 6tmonth history of genital 
swelling. Gynecological examination revealed that she 
had clitoral swelling. Ultrasound revealed a cystic mass, 
which was mostly a clitoral cyst. CT of abdomen and 
chest were free, while a CT of the pelvis showed clitoral 
soft tissue swelling that was 2×3 centimeters in diamt
eter for clinical and pathological evaluation. Alphatfet
toprotein was 1.1 ng/mL (normal range, 0t10 ng/mL). 
She had been misdiagnosed as having congenital adt
renal hyperplasia presenting with clitoromegaly, but 
specific tests (serum cortisol, dehydroepiandrosterone 
sulfate and testosterone) were normal. Surgical resect
tion of the clitoris was done, but a pathological examit
nation was neglected.
The patient presented to us 4 months later with a 
recurrent mass at the mons pubis (Figure 1). The mass 
was hard and about 3×4 centimeters in diameter, fixed 
to the underlying structures and not the skin, but the 
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overlying skin was hyperemic with dilated vessels, and 
no enlarged inguinal lymph nodes. Vaginal inspection 
was free, and the rectal examination was also free. A 
CT of the pelvis showed hypertrophy of the soft tissue 
of the clitoris (Figure 2).
A biopsy was taken from the mass (grayish white, 
2×3.5×2 centimeters) and hematoxylin and eosin 
stain revealed highly pleomorphic small cells with 
small rounded nuclei and large spindletshaped cells 
with vesicular nuclei and acidophilic cytoplasm. The 
tumor cells were disposed in a rich collagenous fit
brous stroma (malignant rounded cell tumor, mostly 
embryonal rhabdomyosarcoma) (Figure 3). A desmin 
stain was positive. Complete surgical excision of the 
mass was done and the patient received chemotherapy 
for rhabdomyosarcoma (VAC protocol scheduled for 
43 weeks: vincristine, 1.5mg/m2 IV; actinomycin D, 
0.015mg/kgm/day IV for 5 days; cyclophosphamide, 
2.2gm/m2 IV with mesna). She also received pelvic 
radiation therapy for 5 weeks. After 10 months, folt
low up MRI revealed the presence of a soft tissue mass 
(3×4×4.5 centimeters) at the site of the previous opt
eration with invasion to the skin only and no invasion 
to underlying bone or interior of the pelvis. The patient 
was surgically operated on again for treatment of this 
local recurrence.
DISCUSSION
Clitoromegaly can be either congenital or acquired. 
The congenital forms are caused by hormonal disturt
bances or intersex states. Usually they are obvious at 
birth. When the clitoromegaly develops later, the unt
derlying etiology should be explored and acquired 
causes should also be considered. These acquired forms 
of clitoromegaly are either hormonal or nonthormonal. 
In the hormonal causes, an androgen excess is the main 
contributing factor for the clitoral enlargement. Three 
groups are generally distinguished: endocrinopathies, 
masculinizing tumors, or selftinjection of longtacting 
synthetic androgens,4 but clitoral tumors should be 
considered in the differential diagnosis. The clitoris 
can be involved in a variety of benign and malignant 
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neoplasms. Among the multiple reports of neoplasms 
involving the clitoris are angiokeratoma,5,6 hemangiot
ma,7 neurotumors associated with neurofibromatosis,8 
keratoacanthoma9 and lymphoma.10 In adults, the most 
common malignancies involve squamous cell carcinot
mas of the vulva that invade the corporal bodies.11,12 
The clitoris is rarely a metastatic site and equally as rare 
is a primary sarcoma of the vulva that may extend to 
the clitoris.13t15
The most common sites of presentation of rhabdot
myosarcoma are genitourinary (29%), parameningeal 
(24%), the extremities (15%), retroperitoneal (13%), 
orbit (8%), other head and neck (7%), and miscellat
neous sites (4%). Most often, rhabdomyosarcoma prest
ents as a rapidly enlarging mass lesion, although often 
the manifestations of tumor growth depend on the prit
mary tumor site.16 The genitourinary sites of this lesion 
in younger females are primarily vaginal, cervical, and 
uterine, with occasional tumor extension to involve the 
urethra and labia. A lesion that originates superficial 
to the introitus is rare, although a few cases of vulvar 
rhabdomyosarcoma exist.17,18
Rhabdomyosarcomas arise in primitive fetal mesent
chyme even at sites that do not contain skeletal muscle. 
It also manifests immunohistochemical expression of 
myosin, actin, desmin, myoglobin and Ztband protein. 
Histologically, there are four subtypes: embryonal, 
alveolar, botryoid and pleomorphic.19 The embryot
nal subtype represents about 54% of rhabdomyosart
comas. This subtype usually occurs before 8 years of 
age and accounts for 80% of genitourinary tumors, 
60% of head and neck tumors and 50% of tumors at 
other sites. The tumor is poorly circumscribed, soft 
and whitish in color. Morphologically, it resembles the 
developing skeletal muscle of the 7t10 week old fetus. 
Rhabdomyoblasts can take several characteristic mort
phologic appearances.20
All patients with rhabdomyosarcoma are presumed 
to have micrometastatic disease at diagnosis, and thus 
successful treatment requires achievement of both lot
cal and systemic control of disease. Systemic control is 
achieved by chemotherapy even for patients with lot
calized disease to eradicate the micrometastasis. The 
chemotherapy regimens used include a combination of 
the effective agents in rhabdomyosarcoma, which are 
cyclophosphamide, ifosfamide, melphalan, actinomyt
cin D, adriamycin, cisplatin, carboplatin, vincristine 
and etoposide. Local control is accomplished by comt
plete surgical excision and/or local irradiation.21 
Clitoral rhabdomyosarcoma in children is a very rare 
tumor, reported only in few cases.22t24 It may have a poor 
prognosis and may be resistant to treatment due to delay 
Figure 1. Clitorial mass after recurrence.
Figure 2. CT of the pelvis showing hypertrophy of the soft tissue 
of the clitoris.
Figure 3. Hematoxylin and eosin stain of the clitoral biopsy 
showing a malignant rounded cell tumor.
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in diagnosis and treatment. Clitoral tumors, although very 
rare, should be considered in the differential diagnosis of 
any clitoral enlargement, especially with normal hormonal 
studies for exclusion of adrenogenital syndromes. 
REfERENCES
